Osaic Holdings’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Osaic Holdings’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-450	Closed	-$1.4K	–	8018
2026 Q1	$1.4K	Sell	450 -1,350	-75%	-$5.58K	﹤0.01%	7164
2025 Q4	$7.2K	Buy	+1,800	New	+$14.1K	﹤0.01%	6513
2025 Q3	–	Sell	-9	Closed	-$189	–	7909
2025 Q2	$189	Buy	+9	New	+$207	﹤0.01%	7511
2025 Q1	–	Sell	-9	Closed	-$293	–	7474
2024 Q4	$293	Hold	9	–	–	﹤0.01%	7125
2024 Q3	$372	Hold	9	–	–	﹤0.01%	7064
2024 Q2	$477	Buy	+9	New	+$426	﹤0.01%	6997
2022 Q1	–	Sell	-6	Closed	-$1K	–	7254
2021 Q4	$1K	Hold	6	–	–	﹤0.01%	7144
2021 Q3	$2K	Buy	+6	New	+$2.36K	﹤0.01%	6829
2021 Q2	–	Hold	0	–	–	–	6996
2021 Q1	–	Hold	0	–	–	–	6806
2020 Q4	–	Hold	0	–	–	–	6404
2020 Q3	–	Hold	0	–	–	–	6214
2020 Q2	–	Hold	0	–	–	–	6121
2020 Q1	–	Hold	0	–	–	–	6063

Other funds holding CANF

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings's CANF Position: Q2 2026 in Review

Osaic Holdings sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2026, closing a stake of 450 shares — an estimated $1.4K sold.

Osaic Holdings first reported a position in CANF in Q3 2021 and held it in 8 quarters. The position peaked at $7.2K in Q4 2025. 8 funds tracked by Wall St. Rank hold CANF as of Q2 2026.

Osaic Holdings reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Osaic Holdings sold 450 Can-Fite BioPharma American Depositary Shares shares in Q2 2026, an estimated $1.4K.
Osaic Holdings first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2021 and held it in 8 quarters.
Osaic Holdings's Can-Fite BioPharma American Depositary Shares position peaked at $7.2K in Q4 2025.
8 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.